批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/05/01 |
SUPPL-50(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/04/29 |
SUPPL-45(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/11/25 |
SUPPL-19(补充) |
Approval |
Labeling |
|
|
|
2014/09/22 |
SUPPL-34(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/09/22 |
SUPPL-32(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/09/22 |
SUPPL-29(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/06/28 |
SUPPL-28(补充) |
Approval |
Labeling |
|
|
|
2009/05/29 |
SUPPL-23(补充) |
Approval |
Labeling |
|
|
|
2007/01/14 |
SUPPL-18(补充) |
Approval |
Labeling |
|
|
|
2005/06/02 |
SUPPL-10(补充) |
Approval |
Labeling |
|
|
|
2002/11/26 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2002/06/05 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:AMOXICILLIN; CLAVULANATE POTASSIUM 剂型/给药途径:FOR SUSPENSION;ORAL 规格:200MG/5ML;EQ 28.5MG BASE/5ML 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
065066 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
200MG/5ML;EQ 28.5MG BASE/5ML |
Prescription |
No |
No |
AB |
2002/06/05
|
SANDOZ |
065098 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
200MG/5ML;EQ 28.5MG BASE/5ML |
Prescription |
No |
No |
AB |
2002/12/16
|
SANDOZ INC |
065089 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
200MG/5ML;EQ 28.5MG BASE/5ML |
Prescription |
No |
No |
AB |
2004/05/25
|
TEVA |
065191 |
002 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
200MG/5ML;EQ 28.5MG BASE/5ML |
Prescription |
No |
No |
AB |
2005/01/25
|
HIKMA PHARMS |
201090 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
200MG/5ML;EQ 28.5MG BASE/5ML |
Prescription |
No |
No |
AB |
2011/12/20
|
AUROBINDO PHARMA LTD |
205187 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
200MG/5ML;EQ 28.5MG BASE/5ML |
Prescription |
No |
No |
AB |
2021/05/21
|
MICRO LABS LTD INDIA |
活性成分:AMOXICILLIN; CLAVULANATE POTASSIUM 剂型/给药途径:FOR SUSPENSION;ORAL 规格:400MG/5ML;EQ 57MG BASE/5ML 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
065066 |
002 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
400MG/5ML;EQ 57MG BASE/5ML |
Prescription |
No |
No |
AB |
2002/06/05
|
SANDOZ |
065098 |
002 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
400MG/5ML;EQ 57MG BASE/5ML |
Prescription |
No |
No |
AB |
2002/12/16
|
SANDOZ INC |
065089 |
002 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
400MG/5ML;EQ 57MG BASE/5ML |
Prescription |
No |
Yes |
AB |
2004/05/25
|
TEVA |
065191 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
400MG/5ML;EQ 57MG BASE/5ML |
Prescription |
No |
No |
AB |
2005/01/25
|
HIKMA PHARMS |
201090 |
002 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
400MG/5ML;EQ 57MG BASE/5ML |
Prescription |
No |
No |
AB |
2011/12/20
|
AUROBINDO PHARMA LTD |
205187 |
002 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
400MG/5ML;EQ 57MG BASE/5ML |
Prescription |
No |
No |
AB |
2021/05/21
|
MICRO LABS LTD INDIA |
210416 |
001 |
ANDA |
AMOXICILLIN AND CLAVULANATE POTASSIUM |
AMOXICILLIN; CLAVULANATE POTASSIUM |
FOR SUSPENSION;ORAL |
400MG/5ML;EQ 57MG BASE/5ML |
Prescription |
No |
No |
AB |
2023/12/11
|
DEVA HOLDING AS |